Mazdutide 10MG

Mazdutide 10MG | Next-Gen Dual Receptor Agonist

A potent co-agonist of GLP-1 and Glucagon receptors, engineered for advanced weight loss and metabolic research.

Mazdutide (formerly IBI362) is a synthetic oxyntomodulin analogue that acts as a dual agonist of both the GLP-1 receptor and the Glucagon receptor. In recent metabolic research, Mazdutide is studied for its ability to combine the appetite-suppressing effects of GLP-1 with the energy-expenditure-increasing properties of glucagon, potentially offering a superior metabolic profile to single-agonist compounds.

Research Benchmarks: Dual-Action Metabolism

• Energy Expenditure: Studying the glucagon-mediated increase in basal metabolic rate.
• Appetite Suppression: Investigating the GLP-1-mediated signals in the hypothalamus.
• Hepatic Lipid Management: Researching the peptide’s impact on liver fat reduction and metabolic dysfunction-associated steatotic liver disease (MASLD).

Scientific Reference Library

• 🧪 Research: Pharmacological profile of Mazdutide in obesity research
• 🧪 Research: Efficacy and safety of the dual agonist Mazdutide
• 🧪 Research: Mechanisms of dual GLP-1/GCGR agonism on body weight